Visualizing the Future of Biology and Medicine Natcher Conference Center, National Institutes of Health, Bethesda, MD, USA - 25-26 June,1999
Charting a vision for the future of biomedical imaging research is the goal
of a two-day symposium presented by the National Institutes of Health with joint
support by AIMBE - American Institute for Medical and Biological Engineering and
RSNA - Radiological Society of North America.
The purpose of this conference is to identify the challenges and opportunities in biomedical imaging science, and, more specifically, to (1) develop strategies for integrating imaging science with biological and medical research, (2) provide a forum for interdisciplinary imaging scientists to discuss the vision and future of biomedical imaging research, and (3) recommend areas of future investment to NIH.
Speakers, panelists, and moderators for the symposium have been selected for their important contributions to the field of biomedical imaging and for their ability to convey a long-term perspective on the future of biomedical imaging. Dr. Harold Varmus, Director of NIH, will open the conference. The first plenary session, addressing challenges for the imaging sciences, will be followed by structured sessions focusing on imaging at the cellular and molecular levels, imaging in the early detection of disease, and imaging in therapy. Poster sessions and exhibits are scheduled to provide concrete examples of the results that can be achieved when engineering principles and methods are applied to the solution of biological problems.
Additionally three panels are scheduled. These deal with:
- phenotyping, genomics, contrast mechanisms, imaging probes, imaging at the end of a catheter, imaging in association with implantable probes or biosensors, metabolic diseases, degenerative diseases, neoplasms, angiogenesis
- temporal, spatial, and contrast resolution needs for early detection; technologies for early detection of inflammatory, metabolic, degenerative, neoplastic disease; functional imaging technologies for early detection; home monitoring; biosensors; image exploitation
- monitoring the effects of therapy, imaging in rational drug/therapy development, site-specific drug delivery, gene therapy, minimally invasive procedures, robotics, image fusion, registration, and visualisation.
For more information contact:
Chipper Whalan
Capital Consulting Corporation
Tel: 301 468 6001
Fax: 301 468 0338
Email: bioimaging@md.capconcorp.com
Website: http://www.capconcorp.com/grants/becon/meeting99/index.asp